Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1.70
Market cap: ₹6.80 Cr
Revenue (annual): ₹115.9 Cr
Net profit (annual): ₹0.39 Cr
P/E (TTM): 15.0×Sector 47.3×
Promoter holding: 20.02%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 2 Other Announcement 1 Management Change 1 Financial Results 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Jul 2026 15:44 IST BSE

Management Change

Vivanza Biosciences Management Change

Vivanza Biosciences appointed Mr. Vishal Sureshbhai Katarmal as Company Secretary and Compliance Officer. The Board also noted a strategic agreement for a manufacturing project in Kyrgyzstan.

Read the filing ↗